慢性丙型肝炎患者中的隐匿性乙型肝炎病毒感染：幕后黑手还是旁观者？ - Suppr

Suppr

超能文献

Occult hepatitis B virus infection in patients with chronic hepatitis C: An actor behind the scene or just a bystander?

作者信息

Chu Chi-Jen, Lee Shou-Dong

出版信息

J Gastroenterol Hepatol. 2010 Feb;25(2):221-3. doi: 10.1111/j.1440-1746.2009.06134.x.

DOI:10.1111/j.1440-1746.2009.06134.x

PMID:20136983

Abstract

摘要

相似文献

Occult hepatitis B virus infection in patients with chronic hepatitis C: An actor behind the scene or just a bystander?

J Gastroenterol Hepatol. 2010 Feb;25(2):221-3. doi: 10.1111/j.1440-1746.2009.06134.x.

Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.

J Gastroenterol Hepatol. 2010 Feb;25(2):259-63. doi: 10.1111/j.1440-1746.2009.06006.x. Epub 2009 Oct 9.

Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.

J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):172-5.

Impact of occult hepatitis B virus infection or hepatitis B virus DNA integration on efficacy of chronic hepatitis C treatment with peginterferon and ribavirin: where are we?

J Clin Gastroenterol. 2014 Jan;48(1):3-5. doi: 10.1097/MCG.0b013e3182a6633d.

Can Peg-IFN alpha-2a plus ribavirin be used to treat patients with chronic hepatitis C and normal alanine aminotransferase levels?

Nat Clin Pract Gastroenterol Hepatol. 2005 Mar;2(3):130-1. doi: 10.1038/ncpgasthep0117.

Drug induced hypersensitivity syndrome by triple therapy of peginterferon alpha2b, ribavirin and telaprevir in patient with double positive for HBV and HCV.

Hepatogastroenterology. 2013 Oct;60(127):1557-60.

Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.

Neth J Med. 2008 May;66(5):191-5.

Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C.

J Clin Virol. 2004 Mar;29(3):160-6. doi: 10.1016/S1386-6532(03)00117-3.

Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection.

Antivir Ther. 2008;13(2):307-18.

Recurrence of hepatitis C virus infection during pityriasis rosea.

Acta Derm Venereol. 2013 Jul 6;93(4):483. doi: 10.2340/00015555-1509.

引用本文的文献

Occult Hepatitis B in Hemodialysis Patients is a Debate.

Adv Biomed Res. 2018 Jun 25;7:104. doi: 10.4103/abr.abr_233_16. eCollection 2018.

Isolated anti-hbc and occult HBV infection in dialysis patients.

Nephrourol Mon. 2014 Nov 30;7(1):e22674. doi: 10.5812/numonthly.22674. eCollection 2015 Jan.

Clinical significance of occult hepatitis B virus infection.

World J Gastroenterol. 2011 Mar 28;17(12):1549-52. doi: 10.3748/wjg.v17.i12.1549.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Occult hepatitis B virus infection in patients with chronic hepatitis C: An actor behind the scene or just a bystander?

作者信息

Chu Chi-Jen, Lee Shou-Dong

出版信息

J Gastroenterol Hepatol. 2010 Feb;25(2):221-3. doi: 10.1111/j.1440-1746.2009.06134.x.

DOI:10.1111/j.1440-1746.2009.06134.x

PMID:20136983

Abstract

摘要

相似文献

Occult hepatitis B virus infection in patients with chronic hepatitis C: An actor behind the scene or just a bystander?

J Gastroenterol Hepatol. 2010 Feb;25(2):221-3. doi: 10.1111/j.1440-1746.2009.06134.x.

Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.

J Gastroenterol Hepatol. 2010 Feb;25(2):259-63. doi: 10.1111/j.1440-1746.2009.06006.x. Epub 2009 Oct 9.

Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.

J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):172-5.

Impact of occult hepatitis B virus infection or hepatitis B virus DNA integration on efficacy of chronic hepatitis C treatment with peginterferon and ribavirin: where are we?

J Clin Gastroenterol. 2014 Jan;48(1):3-5. doi: 10.1097/MCG.0b013e3182a6633d.

Can Peg-IFN alpha-2a plus ribavirin be used to treat patients with chronic hepatitis C and normal alanine aminotransferase levels?

Nat Clin Pract Gastroenterol Hepatol. 2005 Mar;2(3):130-1. doi: 10.1038/ncpgasthep0117.

Drug induced hypersensitivity syndrome by triple therapy of peginterferon alpha2b, ribavirin and telaprevir in patient with double positive for HBV and HCV.

Hepatogastroenterology. 2013 Oct;60(127):1557-60.

Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.

Neth J Med. 2008 May;66(5):191-5.

Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C.

J Clin Virol. 2004 Mar;29(3):160-6. doi: 10.1016/S1386-6532(03)00117-3.

Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection.

Antivir Ther. 2008;13(2):307-18.

Recurrence of hepatitis C virus infection during pityriasis rosea.

Acta Derm Venereol. 2013 Jul 6;93(4):483. doi: 10.2340/00015555-1509.

引用本文的文献

Occult Hepatitis B in Hemodialysis Patients is a Debate.

Adv Biomed Res. 2018 Jun 25;7:104. doi: 10.4103/abr.abr_233_16. eCollection 2018.

Isolated anti-hbc and occult HBV infection in dialysis patients.

Nephrourol Mon. 2014 Nov 30;7(1):e22674. doi: 10.5812/numonthly.22674. eCollection 2015 Jan.

Clinical significance of occult hepatitis B virus infection.

World J Gastroenterol. 2011 Mar 28;17(12):1549-52. doi: 10.3748/wjg.v17.i12.1549.